thrombosis
Information
- Disease name
- thrombosis
- Disease ID
- DOID:0060903
- Description
- "A vascular disease caused by the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system." [url:https\://en.wikipedia.org/wiki/Thrombosis]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05607602 | Active, not recruiting | Are Uterine Fibroids Pro-thrombotic? | October 17, 2022 | December 31, 2024 | |
| NCT05151094 | Active, not recruiting | Registry of Hospitalized Patients in University Hospital Dubrava Respiratory Center | April 1, 2021 | January 1, 2026 | |
| NCT03261284 | Active, not recruiting | N/A | D-dimer to Improve Anticoagulation Outcome During ECMO loNg-term supporteD | March 1, 2019 | December 30, 2023 |
| NCT04912336 | Active, not recruiting | Extracorporeal Life Support and Modification of Hemostasis | May 28, 2021 | April 30, 2024 | |
| NCT00203970 | Active, not recruiting | Diffusion of Use of Low Molecular Weight Heparin for Thrombosis on the Medicine Services | February 2001 | January 2024 | |
| NCT04596501 | Active, not recruiting | N/A | Exercise Training and Thrombotic Risk in Post-menopausal Women | March 1, 2021 | December 31, 2023 |
| NCT00726947 | Completed | Early Phase 1 | Ultrasound Elasticity Imaging of Venous Thrombi | December 2002 | June 2011 |
| NCT00005436 | Completed | Lupus Cohort--Thrombotic Events and Coronary Artery Disease | September 1991 | August 1996 | |
| NCT00736008 | Completed | Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center | May 2008 | August 2009 | |
| NCT04550026 | Completed | N/A | Cardiovascular Effects of Heated Tobacco Products (HTP) | November 1, 2020 | April 1, 2021 |
| NCT04623177 | Completed | Thromboprophylaxis for Patients in ICU With COVID-19 | March 1, 2020 | November 30, 2020 | |
| NCT04646655 | Completed | Phase 3 | Enoxaparin at Prophylactic or Therapeutic Doses in COVID-19 | July 27, 2020 | April 30, 2023 |
| NCT04702113 | Completed | N/A | Evaluating Pharmacogenomic Variants for Cardiology Therapeutics | December 3, 2020 | July 27, 2023 |
| NCT04719182 | Completed | Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19 | September 1, 2020 | April 1, 2021 | |
| NCT04730856 | Completed | N/A | Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID) | February 1, 2021 | December 20, 2021 |
| NCT02982707 | Completed | Phase 1 | Single-dose Pharmacokinetics of BMS-986177 in Participants With Hepatic Impairment Compared to Healthy Participants | March 1, 2018 | September 28, 2018 |
| NCT02997111 | Completed | N/A | PFA-100 Responsive to Effect of Energy Drinks on Platelet Function | February 14, 2017 | June 20, 2017 |
| NCT00320255 | Completed | Phase 2 | A Phase 2 Pilot Study of Apixaban for the Prevention of Thromboembolic Events in Patients With Advanced (Metastatic) Cancer | June 2006 | January 2009 |
| NCT03051230 | Completed | Vascular Cell Activation, Cell-Derived Microparticles and In Vitro Fertilisation, and In Vitro Fertilisation | April 1, 2012 | February 1, 2017 | |
| NCT03097341 | Completed | Phase 1 | Safety and Tolerability Study of Xisomab 3G3 in Healthy Adult Subjects | June 5, 2017 | January 16, 2018 |
| NCT03118115 | Completed | N/A | Bioimpedance Variation of Free Flap for After Clamping | May 10, 2017 | May 19, 2017 |
| NCT00322270 | Completed | Phase 3 | Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Catheters | January 2006 | |
| NCT03161678 | Completed | Phase 4 | CES1 Crossover Trial of Clopidogrel and Ticagrelor | August 22, 2017 | December 12, 2022 |
| NCT00000538 | Completed | Phase 3 | Dietary Effects on Lipoproteins and Thrombogenic Activity | September 1992 | May 1995 |
| NCT03196206 | Completed | Phase 1 | Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment | July 13, 2017 | March 4, 2018 |
| NCT03197779 | Completed | Phase 1 | A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects | November 18, 2013 | January 24, 2017 |
| NCT03199612 | Completed | Early Phase 1 | Sildenafil To Prevent Clot | June 3, 2019 | January 20, 2023 |
| NCT03212898 | Completed | N/A | Pharmacist Interventions in Rural Elderly Warfarin Patients | May 2015 | January 2017 |
| NCT03224260 | Completed | Phase 1 | To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants | June 28, 2017 | November 7, 2017 |
| NCT00345618 | Completed | Phase 3 | Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach | June 2006 | October 2010 |
| NCT03230032 | Completed | N/A | Pacifier Activated Device and Mother's Voice in Infants at High-risk for Cerebral Palsy | June 9, 2017 | July 31, 2021 |
| NCT03251014 | Completed | N/A | Thrombotic Effects of Yellowstripe Scad | October 2016 | May 9, 2017 |
| NCT00346424 | Completed | Phase 3 | Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central Catheters | September 2005 | December 2006 |
| NCT03280368 | Completed | Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation | June 2014 | January 2020 | |
| NCT03292107 | Completed | Study on Management Thrombosis in Greek Cancer Patients | June 1, 2016 | February 28, 2018 | |
| NCT03303820 | Completed | Analysis of the Impact of the Undernutrition on the Cerebral Infarct in Thrombolized Patients | May 27, 2016 | August 31, 2017 | |
| NCT03362437 | Completed | Phase 1 | Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants | November 15, 2017 | December 28, 2017 |
| NCT00352222 | Completed | Phase 3 | Safety and Efficacy of Express LD to Treat Stenosed or Occlusive Atherosclerotic Disease in Iliac Arteries | January 2004 | February 2007 |
| NCT03415789 | Completed | Intraventricular Stasis in Non Ischemic Dilated Myocardiopathy | February 10, 2018 | November 24, 2020 | |
| NCT03453060 | Completed | Phase 1 | Safety and Tolerability Study of E-WE Thrombin in Healthy Adult Subjects | May 30, 2018 | November 25, 2018 |
| NCT03469206 | Completed | N/A | Direct Intra-arterial Thrombectomy in Order to Revascularize AIS Patients With Large Vessel Occlusion Efficiently in Chinese Tertiary Hospitals | February 21, 2018 | October 26, 2019 |
| NCT00363818 | Completed | The Association of Platelet Function and Endothelial Function of the Brachial Artery | January 2006 | March 2008 | |
| NCT00398216 | Completed | Phase 2 | A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery | May 2006 | June 2007 |
| NCT00412464 | Completed | Phase 1 | Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis | September 2006 | December 2009 |
| NCT03612856 | Completed | Phase 2 | Safety and Efficacy Study of AB023 (Xisomab 3G3) in End Stage Renal Disease Patients on Chronic Hemodialysis | October 29, 2018 | July 6, 2019 |
| NCT00432770 | Completed | Phase 1 | Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 in Healthy Volunteers | December 2006 | March 2007 |
| NCT03769831 | Completed | Phase 1 | The PK/PD Study of SHR2285 Tablets in Healthy Subjects | February 25, 2019 | July 22, 2019 |
| NCT00447434 | Completed | Phase 4 | Efficacy and Safety of Natto Extract | June 2005 | October 2005 |
| NCT03826043 | Completed | N/A | THrombo-Embolic Event in Onco-hematology | September 9, 2019 | September 9, 2022 |
| NCT03903302 | Completed | Phase 1 | Study Investigation Pharmacokinetics and Pharmacodynamics of CS1 | October 6, 2017 | March 27, 2018 |
| NCT03939702 | Completed | Phase 1 | Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants | May 2, 2019 | July 11, 2019 |
| NCT03943966 | Completed | N/A | In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer | November 11, 2019 | October 13, 2021 |
| NCT03963895 | Completed | Phase 2 | Safety and Efficacy Study of AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis | July 3, 2019 | December 29, 2020 |
| NCT04131088 | Completed | "Follow-up of Midlines Placed Outside the Intensive Care Unit: What Side Effects? An Observational Study" | December 23, 2019 | December 15, 2022 | |
| NCT00457184 | Completed | Thrombophilia and Migraine, Are They Related? | January 2004 | June 2007 | |
| NCT04175457 | Completed | N/A | The Acute Effects of E-cigarette Inhalation on Vascular Function, Microcirculation and Thrombosis | December 5, 2019 | January 27, 2020 |
| NCT00479362 | Completed | Phase 4 | Anticoagulant Therapy During Pacemaker Implantation | September 2005 | September 2012 |
| NCT00005260 | Completed | Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio) | July 1990 | August 2002 | |
| NCT04305756 | Completed | N/A | Impact of Prophylactic Low-molecular Weight Heparin Dosing on Clotting Parameters Following Cesarean Delivery | June 12, 2020 | December 15, 2021 |
| NCT00005356 | Completed | Novel Hemostatic Cardiac Risk Factors in Framingham | July 1994 | May 1998 | |
| NCT04366778 | Completed | Thrombosis and Covid-19 | May 1, 2020 | January 1, 2021 | |
| NCT04373707 | Completed | Phase 4 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | May 13, 2020 | September 14, 2021 |
| NCT04397289 | Completed | Phase 1/Phase 2 | Anticoagulation Therapy After Splenectomy in Cirrhosis Patient | February 12, 2018 | March 31, 2021 |
| NCT00622115 | Completed | Phase 1 | Etude (Study) Phase I Enox - UnFractionated Heparin (UFH) | July 2007 | November 2007 |
| NCT00005358 | Completed | Thrombogenic Factors and Recurrent Coronary Events | April 1994 | March 1999 | |
| NCT04472819 | Completed | Phase 1 | The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Healthy Subjects | August 28, 2020 | May 31, 2021 |
| NCT04481698 | Completed | Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy | April 1, 2017 | December 1, 2017 | |
| NCT04517461 | Completed | Coagulation and Vitamin K in Head and Neck Microvascular Free Flap Surgery | September 15, 2020 | October 1, 2021 | |
| NCT00660205 | Completed | Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | February 2008 | February 2011 | |
| NCT00716898 | Completed | Pharmacokinetics of Low Molecular Weight Heparin in Cancer Patients | February 2009 | June 2011 | |
| NCT00716924 | Completed | Phase 3 | CASTLE (Clopidogrel And Serum Troponin Level Elevation) | May 2004 | |
| NCT04945616 | Completed | Phase 1 | To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogrel or Ticagrelor in Healthy Subjects | July 13, 2021 | June 15, 2022 |
| NCT04998799 | Completed | Practice Variation on Antithrombotics in COVID-19 | October 1, 2021 | November 10, 2021 | |
| NCT00766896 | Completed | Phase 4 | Platelet Hyperreactivity to Aspirin and Stroke | July 2009 | June 2013 |
| NCT05143567 | Completed | N/A | Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications | November 1, 2021 | July 23, 2023 |
| NCT00000466 | Completed | Phase 3 | Postmenopausal Estrogen/Progestin Interventions (PEPI) | September 1987 | October 2000 |
| NCT05367466 | Completed | Risk Factors of Neonatal Thrombosis | January 1, 2014 | April 10, 2022 | |
| NCT05426564 | Completed | Exploratory Assessment of the Quantra® System in Adult ECMO Patients | September 27, 2022 | June 1, 2023 | |
| NCT05621915 | Completed | Nadroparin Pharmacokinetics in Different Stages of COVID-19 | February 1, 2021 | April 15, 2022 | |
| NCT05666388 | Completed | N/A | Rescue Stenting in the Severe Atherosclerotic Stenosis After the Failure of Intravenous Thrombolysis | May 1, 2020 | November 30, 2022 |
| NCT05884060 | Completed | Retrospective Chart Review Screening Algorithm to Assess the Prevalence of PNH-clones | April 20, 2018 | March 1, 2022 | |
| NCT05977452 | Completed | The Risk Assessment Scale for Peripherally Inserted Central Venous Catheter (PICC) Related Thrombosis in Cancer Patients | April 1, 2023 | January 2, 2024 | |
| NCT00778336 | Completed | A Prospective Observational Registry of Peripheral Use of AngioJet Rheolytic Thrombectomy With Mid-Length Catheters | January 2007 | April 2010 | |
| NCT00779558 | Completed | N/A | Heparin and the Reduction of Thrombosis (HART) Trial | November 2005 | November 2007 |
| NCT00796692 | Completed | Phase 4 | Nadroparin for the Initial Treatment of Pulmonary Thromboembolism | June 2002 | February 2006 |
| NCT00830570 | Completed | The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings | July 2007 | January 2010 | |
| NCT00856765 | Completed | Phase 2/Phase 3 | Drug-eluting Balloon in Acute Myocardial Infarction | March 2009 | November 2016 |
| NCT00913133 | Completed | Phase 4 | Safety Study of Desirudin, an Anticoagulant for the Prophylaxis of Thrombosis | March 2010 | June 2011 |
| NCT00914641 | Completed | Phase 1 | Bioavailability Study Comparing Modified Release To Immediate Release Apixaban Tablets In Healthy Volunteers | June 2009 | August 2009 |
| NCT00005692 | Completed | Inflammation Markers Over Time in Cardiovascular Disease | April 1992 | November 2002 | |
| NCT00990158 | Completed | Phase 3 | Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability? | July 2010 | April 2014 |
| NCT01006486 | Completed | Phase 4 | Outcomes of an Anticoagulation Clinic in an University Hospital | November 2009 | August 2011 |
| NCT00007410 | Completed | Genetic Architecture of Plasma T-PA and PAI-1 | September 2000 | July 2006 | |
| NCT00039767 | Completed | Phase 2 | Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices | May 2002 | April 2006 |
| NCT01042964 | Completed | Phase 1 | Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion | March 2006 | October 2007 |
| NCT00039858 | Completed | Phase 4 | Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin | September 2003 | March 2006 |
| NCT00041405 | Completed | Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D | July 2001 | June 2005 | |
| NCT01070875 | Completed | N/A | Partial Thromboplastin Time During the First 24 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin (UFH) | April 2010 | June 2012 |
| NCT00043277 | Completed | Phase 2 | Study Of Angiomax In Infants Under Six Months With Thrombosis | August 2002 | December 2004 |
| NCT00043940 | Completed | Phase 3 | Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning) | April 1999 | |
| NCT00046605 | Completed | Inflammation Genomics and Atherosclerosis - Ancillary to CARDIA | August 2002 | July 2008 | |
| NCT00055159 | Completed | Phase 1 | Low-Dose rtPA to Treat Blood Clots in Major Arm or Neck Veins | February 19, 2003 | December 10, 2007 |
| NCT01137578 | Completed | N/A | Pediatric Catheter-related Thrombosis Imaging Study | February 2011 | May 2013 |
| NCT01143831 | Completed | N/A | Evaluation of Factors II, VII, IX, X, and Proteins C and S, Following High-dose Vitamin K Supplementation | November 2009 | March 2012 |
| NCT01174862 | Completed | Aspirin Responsiveness and Outcome in Coronary Artery Bypass Graft (CABG) Surgery | June 2010 | June 2013 | |
| NCT01203098 | Completed | Phase 2 | A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty | July 2008 | June 2009 |
| NCT01358422 | Completed | Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery | October 2011 | January 2014 | |
| NCT01379300 | Completed | Phase 1 | A Study to Investigate Biomarkers After Single Doses of Anticoagulants in Healthy Young Male and Healthy Elderly Participants (MK-0000-216 AM1) | May 2011 | December 2011 |
| NCT01392612 | Completed | Phase 4 | Erythropoietin and Platelet Activation Markers | November 2006 | July 2007 |
| NCT01435473 | Completed | Clinical Assessment of Thrombosis in Children After Heart Surgery | July 2011 | December 2015 | |
| NCT00073554 | Completed | Phase 2 | Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion | June 2003 | |
| NCT00073580 | Completed | Phase 3 | Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE) | October 2003 | |
| NCT01527526 | Completed | Depot-medroxyprogesterone Acetate (DMPA) Contraceptive Method and Metabolism | February 2011 | February 2013 | |
| NCT01533441 | Completed | Phase 2 | Vitamin K2 Intervention in Patients With Vitamin K Antagonists | February 2012 | April 2013 |
| NCT00107900 | Completed | Phase 2 | Study of the Efficacy and Safety of DU-176b in Preventing Blood Clots in Patients Undergoing Total Hip Replacement | January 2005 | December 2005 |
| NCT00143715 | Completed | Phase 3 | Oral Vitamin K for Warfarin Associated Coagulopathy | September 2004 | January 2007 |
| NCT01661218 | Completed | Complications and Risk Factors Related With Central Venous Catheters in Cancer Patients | August 2012 | August 2019 | |
| NCT00157651 | Completed | Phase 3 | Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters | February 1999 | March 2007 |
| NCT00001518 | Completed | A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters | January 1996 | November 2000 | |
| NCT01707459 | Completed | The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery | March 2010 | August 2014 | |
| NCT00159185 | Completed | Epidemiology Study in Major Orthopaedic Surgery | January 2004 | May 2006 | |
| NCT00190307 | Completed | Phase 4 | STRATAGEM: Strategy for Managing Antiplatelet Therapy in the Perioperative Period of Non Coronary Surgery | June 2005 | December 2009 |
| NCT01835483 | Completed | Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test | May 2013 | July 2013 | |
| NCT01855516 | Completed | N/A | Partial Thromboplastin Time After 72 Hours of Antithrombotic Prophylaxis Using Unfractionated Heparin | September 2013 | December 2015 |
| NCT01878916 | Completed | Plasma Vitamin and Homocysteine Levels and Thrombosis in Patients With Ph-negative MPNs | January 2003 | June 2004 | |
| NCT01988766 | Completed | Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement | October 2012 | August 2014 | |
| NCT01993914 | Completed | Prevalence of MTHFR Polymorphisms in Venous Disease | February 2011 | November 2014 | |
| NCT00203580 | Completed | Phase 4 | Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) | December 1994 | March 2002 |
| NCT02064439 | Completed | Phase 3 | Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism) | March 5, 2014 | November 4, 2016 |
| NCT02101112 | Completed | Phase 1 | Bioavailability of Apixaban Crushed Tablet | March 2014 | May 2014 |
| NCT02111655 | Completed | N/A | Improving Arteriovenous Fistula Patency | September 1, 2012 | September 29, 2015 |
| NCT02140801 | Completed | Phase 4 | Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel | May 1, 2014 | March 8, 2017 |
| NCT00203658 | Completed | Phase 4 | Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin | April 1997 | October 2000 |
| NCT02270918 | Completed | Phase 1 | Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra | November 2014 | December 2014 |
| NCT02295475 | Completed | Phase 4 | Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid Syndrome | December 10, 2014 | March 2022 |
| NCT02307318 | Completed | Phase 1/Phase 2 | Heart and Hands Study II: A Retrospective Data Collection & Analysis Project | November 2014 | June 2015 |
| NCT02341638 | Completed | Phase 1 | Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986141 in Healthy Subjects | September 2014 | September 2015 |
| NCT02373332 | Completed | Fatty Acid Regulation of Platelet Function in Diabetes | August 2013 | May 21, 2019 | |
| NCT02376361 | Completed | N/A | Hemodialysis Access Surveillance Evaluation Study | March 2015 | July 2019 |
| NCT02439190 | Completed | Phase 1 | CV004-007 Thrombosis Chamber Study | September 2015 | March 2016 |
| NCT02486367 | Completed | Phase 4 | Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR) | June 2015 | January 2019 |
| NCT02497716 | Completed | Phase 1 | Phase I Study on Rivaroxaban Granules for Oral Suspension Formulation in Children | November 4, 2015 | May 22, 2018 |
| NCT00237328 | Completed | Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery | June 2006 | July 2012 | |
| NCT02526628 | Completed | Thrombosis and Neurocognition in Klinefelter Syndrome | September 2015 | August 21, 2019 | |
| NCT02608970 | Completed | Phase 1 | Safety and Tolerability Study of BMS-986177 in Healthy Subjects | December 31, 2015 | July 23, 2017 |
| NCT02629497 | Completed | Early Phase 1 | Role of 12-lipoxygenase in Platelet Reactivity and Type 2 Diabetes Mellitus | November 2015 | June 2017 |
| NCT02639143 | Completed | Phase 4 | Rapid P2Y12 Receptor Inhibition Attenuates Inflammatory Cell Infiltration in Thrombus Aspirated From the STEMI Patients | December 2015 | December 2017 |
| NCT02671461 | Completed | Phase 2 | Safety and Efficacy Study of a Protease Activated Receptor-4 Antagonist Being Tested to Reduce the Chances of Having Additional Strokes or "Mini Strokes" | April 25, 2016 | March 31, 2017 |
| NCT02716402 | Completed | N/A | Cyanotic Heart Disease and Thrombosis | November 2015 | November 2017 |
| NCT02807909 | Completed | Phase 1 | A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Pharmacokinetics of BMS-986177 in Healthy Subjects | July 2016 | August 2016 |
| NCT02833948 | Completed | Phase 3 | Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) | May 2016 | March 6, 2019 |
| NCT02846532 | Completed | Phase 3 | Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure | November 16, 2016 | July 16, 2020 |
| NCT02902679 | Completed | Phase 1 | A Study to Evaluate the Safety and Pharmacokinetics of BMS-986177 in Participants With End-stage Renal Dysfunction on Chronic Stable Hemodialysis Treatment | November 2016 | June 2017 |
| NCT02917213 | Completed | Imaging Silent Brain Infarct And Thrombosis in Acute Myocardial Infarction | September 2016 | January 1, 2022 | |
| NCT02959060 | Completed | Phase 1 | A Study to Evaluate the Effect of Rifampin on the Single-dose Pharmacokinetics of BMS-986177 in Healthy Subjects | November 2016 | December 2016 |
| NCT02981472 | Completed | Phase 2 | A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation | January 19, 2017 | October 18, 2021 |
| NCT06386107 | Not yet recruiting | N/A | Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis | June 2024 | August 2026 |
| NCT06153394 | Not yet recruiting | Phase 3 | Prolonged Hypercoagulability Following Major Liver Resection for Malignancy | June 1, 2024 | February 1, 2028 |
| NCT06434207 | Not yet recruiting | Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis | June 1, 2024 | June 1, 2025 | |
| NCT04611191 | Not yet recruiting | N/A | The Effect of Team Sports on the Risk of Thrombosis in Elderly Individuals in a Municipality Setting (TEAM-AGE) | December 30, 2024 | December 31, 2027 |
| NCT06318754 | Not yet recruiting | Large-Bore Mechanic Thrombectomy for the Treatment of Symptomatic Portomesenteric Vein Thrombosis | June 2024 | June 2026 | |
| NCT06329921 | Not yet recruiting | N/A | Inpatient Monitoring of Unfractionated Heparin | May 2024 | May 2026 |
| NCT06242353 | Not yet recruiting | Coagulopathy in Childhood Acute Lymphoblastic Leukaemia | March 1, 2024 | November 2028 | |
| NCT06370273 | Not yet recruiting | Phase 3 | Thromboprophylaxis in Lower Limb Immobilisation | May 2024 | February 2028 |
| NCT05554055 | Not yet recruiting | Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery) | November 2022 | November 2024 | |
| NCT05830916 | Not yet recruiting | Diagnostic Role of Antiphospholipid Antibodies and Microparticles in Immune Thrombocytopenic Patients With Thrombosis | September 2024 | September 2027 | |
| NCT05569798 | Not yet recruiting | N/A | The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial | December 4, 2023 | December 1, 2024 |
| NCT06113510 | Not yet recruiting | Non-invasive Coronary Thrombus Imaging to Define These Cause of Acute Myocardial Infarction | January 2025 | August 2027 | |
| NCT05923658 | Not yet recruiting | How Clinicians Manage Their Patients Who May Need Antithrombotic Care | October 1, 2023 | December 1, 2023 | |
| NCT05628948 | Recruiting | Vascular Lab Resource (VLR) Biorepository | November 14, 2019 | June 30, 2031 | |
| NCT05631847 | Recruiting | N/A | Direct Endovascular Treatment Versus Bridging Treatment In Basilar Artery Occlusive Stroke | April 17, 2023 | May 31, 2027 |
| NCT05636748 | Recruiting | The Origin and Role of Thromboembolism in the Pathogenesis of Ischaemic Stroke | February 28, 2023 | August 2025 | |
| NCT05663281 | Recruiting | Thrombus Imaging and Treatment Analytics in Neurology | December 15, 2022 | December 31, 2027 | |
| NCT03568890 | Recruiting | Phase 4 | Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure | September 1, 2018 | September 1, 2026 |
| NCT05864638 | Recruiting | A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke | May 10, 2023 | August 31, 2028 | |
| NCT05371925 | Recruiting | Phase 3 | Endothelial Protection in Post COVID-19 Patients With Sulodexide | July 26, 2022 | September 19, 2023 |
| NCT04398628 | Recruiting | ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | September 30, 2020 | December 2035 | |
| NCT05028868 | Recruiting | Clinical Research of Intravenous Thrombolysis for Ischemic Stroke in Northeast of China | June 1, 2015 | January 28, 2026 | |
| NCT03255928 | Recruiting | Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) | June 29, 2017 | December 31, 2025 | |
| NCT05068414 | Recruiting | Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients With Atrial Fibrillation | April 12, 2021 | October 2024 | |
| NCT05115799 | Recruiting | N/A | Effects of a Manual Therapy Program to Reduce the Evolution Time of Axillary Web Syndrome | December 1, 2021 | December 4, 2024 |
| NCT05116995 | Recruiting | Phase 4 | Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome Patients | November 1, 2021 | November 1, 2023 |
| NCT05245877 | Recruiting | Phase 4 | Pre- vs. Postoperative Thromboprophylaxis in Pancreatic Surgery | August 17, 2022 | September 2026 |
| NCT06357403 | Recruiting | Association of Anti-factor Xa Activity With Venous Thromboembolism in Critically Ill Patients | May 4, 2024 | August 2026 | |
| NCT04829825 | Recruiting | The "MyoThrombus" Study | December 2, 2020 | December 1, 2025 | |
| NCT05507645 | Recruiting | Phase 3 | ProUrokinase in Mild IsChemic strokE (PUMICE) | October 21, 2022 | June 2024 |
| NCT05575466 | Recruiting | Thromboembolism in Anorexia Nervosa | November 15, 2022 | November 30, 2026 | |
| NCT04644653 | Recruiting | Ex Vivo Test of New Stroke Treatment Using Magnetic Nanorobots | September 1, 2020 | September 30, 2025 | |
| NCT06055907 | Recruiting | Influence of Vasopressors on Anti-Xa Activity in Critically Ill Patients | May 15, 2023 | September 2024 | |
| NCT06062329 | Recruiting | N/A | SYMPHONY-PE Study for Treatment of Pulmonary Embolism | December 8, 2023 | April 2025 |
| NCT06115070 | Recruiting | Phase 4 | ALteplase in Patients With LOW NIHSS and Specified Disabling Deficits | November 17, 2023 | November 30, 2026 |
| NCT06116617 | Recruiting | Phase 1 | A Phase 1 Study to Evaluate the Safety, Tolerability, PK/PD of SRSD107 in Healthy Participants | January 23, 2024 | August 2025 |
| NCT04615065 | Recruiting | Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine | September 1, 2020 | September 1, 2030 | |
| NCT01934725 | Recruiting | Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome | November 2013 | December 2031 | |
| NCT03830320 | Recruiting | Phase 1 | Positron Emission Tomography (PET) Imaging of Thrombosis | April 1, 2016 | January 30, 2026 |
| NCT04262492 | Recruiting | International Registry of Thrombotic APS Patients Treated With Direct Oral Anticoagulants | October 21, 2020 | April 2030 | |
| NCT05592054 | Suspended | N/A | Proximal TEmporary oCclusion Using Balloon Guide Catheter for Mechanical Thrombectomy | November 20, 2022 | December 31, 2024 |
| NCT04746339 | Terminated | Phase 4 | Apixaban for PrOphyLaxis of thromboemboLic Outcomes in COVID-19 | March 4, 2021 | May 30, 2022 |
| NCT01875185 | Terminated | Phase 4 | Hormones Inflammation and Thrombosis | December 2012 | November 2013 |
| NCT00303420 | Terminated | Phase 4 | Alteplase for Blood Flow Restoration in Hemodialysis Catheters | September 2004 | December 2008 |
| NCT01367769 | Terminated | Venous Vascularization and Inflammation on Contrast-enhanced Ultrasound (CEUS) in Patients With Thrombosis | March 2011 | March 2017 | |
| NCT00311896 | Terminated | Phase 3 | Efficacy & Safety of Prophylaxis With Bemiparin in Cancer Patients With a Central Venous Catheter (BECAT) | July 2005 | December 2010 |
| NCT02459613 | Terminated | Phase 1/Phase 2 | Assessment of Radiolabeled rhAnnexin V-128 in Infective Endocarditis | February 5, 2016 | May 2017 |
| NCT00265005 | Terminated | Phase 1 | Safety and Efficacy of Tissue Plasminogen Activator (tPA) in Neonates and Infants | June 2005 | December 2012 |
| NCT03594175 | Terminated | Phase 3 | Efficacy and Safety of CUSA-081 in the Restoration of Central Venous Access Device (CVAD) Functionality | February 12, 2020 | July 10, 2023 |
| NCT02872649 | Terminated | Phase 2 | Dabigatran as an Alternative Anticoagulant in Patients With Left Ventricular Assist Device (LVAD) | January 2013 | February 2016 |
| NCT01612884 | Terminated | Phase 4 | Antiplatelet Therapy Guided by Thrombelastography in Patients With Acute Coronary Syndromes (TEGCOR Study) | August 2011 | March 2017 |
| NCT01148940 | Terminated | Sickle Cell Trait and the Risk of Venous Thromboembolism | July 2010 | June 2011 | |
| NCT02198937 | Terminated | Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans | June 2014 | March 2016 | |
| NCT00379366 | Terminated | Phase 2/Phase 3 | External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access | December 2006 | January 2009 |
| NCT01817257 | Terminated | Phase 2 | Anticoagulation Length in Cancer Associated Thrombosis | December 2013 | February 2015 |
| NCT01820962 | Terminated | Phase 3 | Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients | July 2006 | July 2012 |
| NCT05252923 | Unknown status | Phase 4 | Endothelial Protection in Convalescent COVID-19 Patients | April 1, 2022 | December 31, 2022 |
| NCT00004564 | Unknown status | N/A | The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A | ||
| NCT00157664 | Unknown status | Long Study - Longitudinal Thrombosis in End Stage Renal Disease | July 2004 | December 2008 | |
| NCT00336596 | Unknown status | Phase 3 | Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion | June 2006 | June 2009 |
| NCT00481806 | Unknown status | Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass Surgery | February 2007 | December 2013 | |
| NCT00517257 | Unknown status | Phase 3 | Atorvastatin for the Treatment of Retinal Vein Occlusion | August 2007 | September 2009 |
| NCT00653601 | Unknown status | Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery | April 2008 | April 2011 | |
| NCT00733434 | Unknown status | Phase 4 | The Use of Prostaglandin E1 in Head and Neck Microsurgery | July 2008 | July 2010 |
| NCT00983112 | Unknown status | Phase 4 | Evicel Study on the Peri-operative Bleeding in Total Knee Prothesis Surgery | September 2009 | December 2012 |
| NCT01020110 | Unknown status | Study in an Ex-vivo Thrombosis Model With Human Umbilical Vein Endothelial Cells (HUVEC)-Perfusion | November 2009 | April 2012 | |
| NCT01021488 | Unknown status | Phase 4 | Rosuvastatin for Preventing Deep Vein Thrombosis | October 2009 | March 2012 |
| NCT01046942 | Unknown status | Phase 3 | ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery | November 2008 | September 2014 |
| NCT01063426 | Unknown status | Phase 4 | Re-STOP DVT: Reload of High Dose Atorvastatin for Preventing Deep Vein Thrombosis in Statin Users | November 2009 | March 2012 |
| NCT01086046 | Unknown status | N/A | Study of Blood Clotting After Transcatheter Atrial Septal Defect Closure | January 2009 | June 2012 |
| NCT01102790 | Unknown status | Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure | April 2010 | October 2010 | |
| NCT01106573 | Unknown status | Associations Between Diabetes, Arterial Stiffness and Fibulin-1 in Patients Undergoing Heart- and Vascular Surgery? | June 2010 | May 2013 | |
| NCT01114074 | Unknown status | Thrombus Formation Under Different Flow-conditions | May 2011 | April 2017 | |
| NCT01443273 | Unknown status | Thrombophilic Risk Factors in Preterm and Infants Treated at Ha'Emek Medical Center Between the Years 1990 to 2010 | October 2011 | December 31, 2020 | |
| NCT01478282 | Unknown status | Phase 4 | Reversal of the Antithrombotic Action of New Oral Anticoagulants | January 2012 | December 2012 |
| NCT01595763 | Unknown status | Diagnostic Approach of Deep Vein Thrombosis in Primary Care | November 2011 | ||
| NCT01642979 | Unknown status | Phase 2 | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Classic Paroxysmal Nocturnal Hemoglobinuria | July 2012 | July 2017 |
| NCT01670474 | Unknown status | Phase 4 | Prolonged Hemodialysis Catheter Survival With Copolymer Coating and Rt-PA | January 2011 | November 2012 |
| NCT01705665 | Unknown status | Histopathology of the Aspirated Thrombus During Acute Myocardial Infarction | January 2012 | December 2013 | |
| NCT01760096 | Unknown status | Phase 2 | Safety and Efficacy of Levamisole Combined With Cyclosporine A in Patients With Subclinical Paroxysmal Nocturnal Hemoglobinuria and PNH in the Setting of Another Bone Marrow Failure Syndromes(PNH-2013) | January 2013 | July 2017 |
| NCT01823185 | Unknown status | Phase 4 | Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy | March 2013 | March 2016 |
| NCT02055131 | Unknown status | Phase 4 | Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis | November 2013 | March 2015 |
| NCT02240953 | Unknown status | N/A | Anticoagulation Regiments in Patients With Prosthetic Heart Valve Thrombosis | January 2009 | March 2015 |
| NCT02445690 | Unknown status | Thrombin Generation in Crohn's Disease | May 2015 | April 2017 | |
| NCT02522221 | Unknown status | Phase 3 | Tecarfarin Anti-Coagulation Trial (TACT) | June 1, 2018 | July 1, 2019 |
| NCT02805335 | Unknown status | N/A | Comparison Between Sutureless Devices for PICC and a New System KT FIX PLUS | April 2016 | December 2017 |
| NCT02972385 | Unknown status | Pharmacogenomics of Warfarin in Hispanics and Latinos | September 2016 | September 2022 | |
| NCT02974920 | Unknown status | Phase 4 | Rivaroxaban or Aspirin for Biological Aortic Prosthesis | January 1, 2017 | November 2022 |
| NCT03001544 | Unknown status | Phase 1 | Study of Safety and Biomarker Efficacy of TS23 in Healthy Volunteer | July 2015 | June 2017 |
| NCT03121183 | Unknown status | Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers | March 2015 | June 2018 | |
| NCT03180567 | Unknown status | N/A | Pharmacogentic Screening of Coumarine Based Oral Anticoagulant Using Next Generation Seguencer | June 6, 2017 | December 2020 |
| NCT03226626 | Unknown status | Phase 2/Phase 3 | Tumescent Anesthesia Antibiotic Delivery (TAAD) | December 1, 2021 | July 31, 2022 |
| NCT03269019 | Unknown status | Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia | November 20, 2017 | December 31, 2019 | |
| NCT03392831 | Unknown status | N/A | PIcc Cost EffectiveneSS and Safety of Infusional Therapy | April 2018 | December 2021 |
| NCT03483181 | Unknown status | Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Using Propensity Score Matching | January 1, 2018 | December 31, 2018 | |
| NCT03490552 | Unknown status | N/A | RNA Sequencing Analysis in Large Vessel Occlusion Stroke DATA Bank | January 1, 2018 | January 31, 2022 |
| NCT03560219 | Unknown status | Association of Genetic Polymorphisms With Atrial Fibrosis and Thrombogenic Substrate in Patients With Non-valvular Atrial Fibrillation | July 1, 2018 | December 1, 2019 | |
| NCT03599700 | Unknown status | Risk Factors and Predictors of Thrombosis in Myeloprolferative Neoplasms | December 20, 2019 | December 31, 2022 | |
| NCT03649594 | Unknown status | Risk Stratification Post TAVI Using TEG | October 1, 2020 | April 30, 2023 | |
| NCT03782870 | Unknown status | Cardiovascular Involvement in Patients With Granulomatosis With Polyangiitis | February 1, 2010 | December 30, 2019 | |
| NCT04164693 | Unknown status | N/A | Efficacy and Safety of Short-term Postoperative Anticoagulant Therapy to Prevente Thrombosis in Arterovenous Fistula | January 1, 2019 | October 1, 2020 |
| NCT04248348 | Unknown status | Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients | December 1, 2018 | December 2020 | |
| NCT04301362 | Unknown status | Biomarkers of Thrombosis as Predictors of Venous Thromboembolism Risk in Cancer Patients | July 19, 2019 | December 19, 2021 | |
| NCT04357847 | Unknown status | Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection | April 9, 2020 | August 31, 2021 | |
| NCT04405232 | Unknown status | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK | May 25, 2020 | June 25, 2021 | |
| NCT04445623 | Unknown status | Phase 3 | Prasugrel in Severe COVID-19 Pneumonia | July 2020 | January 2021 |
| NCT04519398 | Unknown status | Investigating the Involvement of ACE and Angiotensinogen Genes' Polymorphism Along With Other Thrombophilic Genotypes in Severe Forms of COVID-19 With/Without Thrombotic Events | August 18, 2020 | August 18, 2021 | |
| NCT04536272 | Unknown status | Phase 3 | Reduced Anticoagulation Targets in ECLS (RATE) | October 1, 2020 | March 1, 2024 |
| NCT04595110 | Unknown status | Hemostatic Profile in Patients Affected by COVID-19 | March 25, 2020 | May 10, 2021 | |
| NCT04796740 | Unknown status | Thrombembolism After Robot- Assisted Surgery in Urology | December 17, 2019 | December 31, 2021 | |
| NCT04896203 | Unknown status | Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease | November 18, 2020 | February 15, 2022 | |
| NCT04910971 | Unknown status | Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year | January 31, 2021 | July 28, 2022 | |
| NCT05067153 | Unknown status | Phase 4 | Thromboprophylaxis in Oesophageal Cancer Patients | May 1, 2021 | May 1, 2024 |
| NCT05342038 | Withdrawn | N/A | Study on the Efficacy and Safety of T-02 for the Treatment for Acute Ischemic Stroke | April 22, 2022 | April 30, 2023 |
| NCT03145870 | Withdrawn | N/A | Prevalence of Asymptomatic Thrombosis in Multiple Myeloma | June 3, 2014 | May 16, 2017 |
| NCT02807441 | Withdrawn | Phase 3 | Perioperative Bleeding and Aspirin Use in Spine Surgery | July 2016 | December 2019 |
| NCT00879957 | Withdrawn | N/A | Heparin Versus no Heparin on Duration of Peripherally Inserted Central Catheter (PICC) Patency in Neonates | January 2010 | May 2011 |
- Disase is a (Disease Ontology)
- DOID:178
- Cross Reference ID (Disease Ontology)
- MESH:D013927
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013927